Skip to main content
  • Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre

    Highlights

    • The median duration of support was 5 days and the maximum duration of support with a 5.0 pump was 62 days.
    • Haemodynamic parameters improved within 24 h of Impella implantation.
    • We observed significant reductions in inotropic support and improvement in renal function, liver function and tissue perfusion.

    Abstract

    Introduction

    The Impella family of devices are short-term mechanical circulatory support (MCS) pumps that hold promise in treating patients with acute cardiogenic shock, acting as bridge to recovery, transplant or durable left ventricular assist device. We assessed the clinical utility, indications and outcomes of the Impella family of devices in a tertiary centre.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details